A Randomized, Double-blind, Placebo-controlled Phase I Study to Determine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of PMZ-2010 (Centhaquin) in Healthy Male Volunteers

Trial Profile

A Randomized, Double-blind, Placebo-controlled Phase I Study to Determine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of PMZ-2010 (Centhaquin) in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Dec 2016

At a glance

  • Drugs Centhaquin (Primary)
  • Indications Hypovolaemic shock; Postoperative pain
  • Focus Adverse reactions
  • Sponsors Pharmazz
  • Most Recent Events

    • 30 Nov 2016 Results from this trial were presented at the American Heart Association Scientific Sessions 2016, as reported by a Pharmazz media release.
    • 16 Nov 2016 Results of compartmental analysis, presented at the 89th Annual Scientific Sessions of the American Heart Association.
    • 27 Apr 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top